Corvus Pharmaceuticals (CRVS) News
NASDAQ: CRVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.67-0.34 (-3.40%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CRVS news summary
We found 6 recent headlines mentioning Corvus Pharmaceuticals (CRVS): 0 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. For price context, CRVS is down 3.40% at $9.67. The most recent story, "Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference in London", was published by GlobeNewswire on Nov 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Corvus Pharmaceuticals headlines
- Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference in LondonCorvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference in LondonGlobeNewswire
- Corvus Pharmaceuticals Reports Third Quarter 2026 Financial ResultsCorvus Pharmaceuticals, Inc. reported its financial results for the third quarter ended September 30, 2026, and provided a business update on its clinical pipeline. As of September 30, 2026, the…Nasdaq
- Corvus Pharmaceuticals GAAP EPS of -$0.22 misses by $0.02Seeking Alpha
- Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2026 Financial ResultsEnrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PTCL) and Phase 2 atopic dermatitis trials on trackGlobeNewswire
- Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68ᵗʰ American Society for Hematology Annual Meeting & ExpositionCorvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with ALPS will be Presented at the 68th ASH Annual MeetingGlobeNewswire
- Noteworthy Thursday Option Activity: NOW, WOLF, CRVSAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ServiceNow Inc (Symbol: NOW), where a total of 96,914 contracts have traded so far,…NasdaqNOW, WOLF, CRVS